Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis

Details for Australian Patent Application No. 2007299920 (hide)

Owner BrainCells, Inc.

Inventors Lorrain, Kym I.; Morse, Andrew; Barlow, Carrolee; Treuner, Kai; Carter, Todd A.

Agent Spruson & Ferguson

Pub. Number AU-A-2007299920

PCT Pub. Number WO2008/036678

Priority 60/826,206 19.09.06 US

Filing date 18 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/19 (2006.01)

A61K 31/216 (2006.01)

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036678 Priority application(s): WO2008/036678

25 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read PPAR Mediated Modulation of Neurogenesis

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299926-Electrically-operated shaft brake with manual positive lock and rotary release and automatic reset feature

2007299918-Location quality of service indicator